Advertisement
Canada Markets open in 1 hr 2 mins
  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CAD/USD

    0.7310
    -0.0001 (-0.0132%)
     
  • CRUDE OIL

    79.70
    +0.44 (+0.56%)
     
  • BTC-CAD

    86,394.30
    +2,703.62 (+3.23%)
     
  • CMC Crypto 200

    1,307.86
    -50.15 (-3.69%)
     
  • GOLD FUTURES

    2,380.30
    +40.00 (+1.71%)
     
  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    18,284.25
    +69.75 (+0.38%)
     
  • VOLATILITY

    12.78
    +0.09 (+0.71%)
     
  • FTSE

    8,447.14
    +65.79 (+0.78%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6779
    +0.0001 (+0.01%)
     

Forget Aurora Cannabis, Cresco Labs Is a Better Marijuana Stock

Forget Aurora Cannabis, Cresco Labs Is a Better Marijuana Stock

The popular Canadian marijuana players have always been investors' favorites: Aurora Cannabis (NYSE: ACB) and Canopy Growth (NASDAQ: CGC) grabbed all the attention after Canada legalized recreational pot in October of 2018. Marijuana was labeled as an essential item in the U.S., and demand rose during lockdowns. Illinois-based pot company Cresco Labs (OTC: CRLBF) saw some explosive revenue numbers in its recent third quarter ended Sept. 30.